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In the course ot a screening program for tyrosine kinase inhibitors, the chloroform extract of a tropical plant, Desmos chinensis, strongly inhibited 
the enzyme activity. The active substance was purified by silica gel, gel filtration, and finally crystallized. The structure was elucidated by mass 
spectrometry and X-ray crystallography to be 8-formyl-2,5,7-trihydroxy-6-methylflavanone, a d we named it desmal. Desmal competed with 
peptide substrate and non-competed with ATP. It inhibited tyrosine kinase in situ in epidennal growth factor (EGF) receptor-overexpressing 
NIH3T3 (ER12) cells. It also inhibited EGF-induced inositol phosphate formation and morphological changes. 
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1. INTRODUCTION 
A variety of mitogen receptors and oncogene prod- 
ucts possess tyrosine kinase activity. Of them, espe- 
cially, epidermal growth factor (EGF) receptors are 
often overproduced in tumour cells [1,2], and erb B2 
products are often overexpressed in breast carcinomas 
[3]. The abl oncogene is activated in most chronic my- 
elogenous leukemia by translocation, which results in 
activation of the tyrosine kinase in the abl oncogene 
product [4]. Therefore, tyrosine kinase inhibitors may 
help to suppress development of these neoplasms. 
We have isolated tyrosine kinase inhibitors such as 
erbstatin [5] and lavendustin A [6] from microorgan- 
isms. However, screening of microorganisms has been 
so popular that it becomes difficult to avoid the 
rescreening of known compounds. For example, we 
often isolate genistein and staurosporin from Strepto- 
myces as tyrosine kinase inhibitors. So, we began 
screening for tyrosine kinase inhibitors from tropical 
plant extracts, and isolated a new flavanone compound, 
desmal (Fig. 1). We also studied the mechanism of inhi- 
bition and biological activity of desmal. 
2. MATERIALS AND METHODS 
2.1. Materials 
ER12 cells [7] were kindly supplied by Dr. M. Shibuya, Institute of 
Medical Science, University of Tokyo. [Y-~~P]ATP (10 Ci/mmol) and 
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[‘H]inositol(23 Ci/mmol) were purchased from DuPont-New England 
Nuclear. 
2.2. Preparation of the chloroform extracts 
Both leaves and stems of Desmos chinensis were crushed into pieces. 
The dried material (50 g) was extracted 3 times by vortexing with 200 
ml of chloroform for 8 h each time to give 3.3 g of oily material. 
2.3. Isolation of desmal 
The extract (450 mg) was dissolved in a small amount of hexane. 
applied to a silica gel column, and eluted with a mixture of hexane- 
ethyl acetate (8/l). The active fractions were combined and dried to 
give a yellow powder (160 mg). This residue was dissolved in MeOH 
and subjected to Toyopearl HW-40 column chromatography. After 
elution with MeOH, the active fractions were combined and dried to 
yield a yellow powder (140 mg). Next, it was dissolved in ethyl acetate, 
and the mixture was washed with 1 N HCl and H,O. The organic layer 
was dried over Na,SO, and concentrated in vacua to give a yellow 
powder. It was crystallized from benzene/toluene/methanol to yield 80 
mg of desmal. 
2.4. Physico-chemical properties 
Desmal crystals appeared as pale yellow needles. They were soluble 
in MeOH, EtOAc, CHCl,, DMSO, Me&O, but not in H20. 
Desmal melted at 164167°C. The UV spectra showed maxima at 
270 nm (E 630) and 340 nm (E 85) in MeOH, at 270 nm (E 660) and 
340 nm (E 85) m 0.1 N HCI, and at 290 nm (E 430), 340 nm (E 2S), and 
390 nm (E 360) in 0.1 N NaOH. 
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Fig. 1. Desmal. 
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Fig. 2. Molecular structure of desmal drawn by PLUTO. There are 
two planes in the molecule: one formed by C(l ‘tC(6’) atoms and the 
other involving C(4A), C(5), C(6), C(7), C(8), C(8A), C(4), O(ll), 
C(12). 0(13), C(14), C(4) and O(10) atoms. The dihedral angle be- 
tween the two planes is 25.8”. The oxygen atom O(9) forms an intra- 
molecular hydrogen bond with O(10) [O(9) ... O(10) = 2.790(S) A]. 
The IR spectra of desmal peaks at 3,341, 2,928, 1,630, 1,446, gave 
1,329, 1,221, 1,201, 1,141, 1,018,979,945,902,756, 7 0 and 19 cm-‘. 
2.5. X-ray structure analysis 
Transparent prism crystals of desmal were grown in benzene/tolu- 
ene/methanol solution. A crystal having approximate dimensions of 
0.3 x 0.1 x 0.1 mm was mounted on a goniometer head for the diffrac- 
tion experiment. All measurements were made with a Rigaku AFCSR 
diffractometer using/?-filtered CuKa radiation. The crystal of desmal 
was monoclinic and belonged to the space group P2Jn. The cell dimen- 
sions were as follows: a = 12.940(l) A, b = 6.3589(9) A, c = 18.352(l) 
A, /3 = 105.007(6)0. The Z value, Dx, and p for CuKa were 4, 1.431 
g cmm3, and 8.8 cn-‘, respectively. The intensity data were collected 
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by the w - 28 scan technique to a maximum 28 value of 123.9”. A total 
of 1,308 independent reflections (I > 30) was used for the subsequent 
structure determination. The structure was solved by the direct 
method [8] and refined by the method of full-matrix least-squares. All 
hydrogen atoms were located on the difference Fourier map. The final 
R-value was 0.061. The molecular structure was drawn by PLUTO [9]. 
Atomic coordinates for this structure have been deposited with the 
Cambridge Crystallographic Data Centre and can be obtained on 
request from Dr. Olga Kennard, University Chemical Laboratory, 
Lensfield Road, Cambridge CB2 IEN, UK. 
2.6. EGF receptor-associated tyrosine kinase assay 
EGF receptor-associated tyrosine kinase activity was measured by 
the method described before [5]. In brief, the reaction mixture con- 
tained 1 mM MnC&, 100 ng of EGF, 40 /g of protein of A431 
membrane fraction [lo], 75 ,ug of albumin, 3 pg of histone in 50~1 of 
HEPES (20 mM, pH 7.4) buffer. The reaction tubes were placed on 
ice and incubated for 10 min in the presence or absence of inhibitor. 
The reaction was initiated by the addition of [y-j2P]ATP (10 PI), and 
the incubation was continued for 30 min at 0°C. Then the reaction was 
stopped by the addition of cold 10% TCA (200,ul) containing 0.01 M 
sodium pyrophosphate and kept at 0°C for 15 min. Finally, TCA- 
insoluble material was collected on glass filter papers by use of a cell 
harvester and counted in a liquid scintillation counter. The kinetic 
study was carried out as described before [6]. 
2.7. Intracellular tyrosine phosphorylation 
ER12 cells (2 x 10’) were plated in 3.5-mm plastic dishes and cul- 
tured in 2 ml of DMEM containing 5% calf serum for 60 h. During 
this period the cells became quiescent by density-dependent i hibition. 
The cells were first preincubated with desmal (25 or 50 &ml) for 3 
h, and then washed twice with 0.5 ml of serum-free DMEM and given 
1 ml of serum-free DMEM containing 100 PM orthovanadate and 
desmal (25 or 50 &ml). After incubation for 1 h, 100 &ml of EGF 
was added. After incubation for 5 min, the cells were washed twice 
with Dulbecco’s phosphate-buffered saline (PBS), scraped into PBS, 
and collected by centrifugation at 15,000 xg for 5 min at 4°C. The 
precipitate was then dissolved in 50 ~1 of 10 mM HEPES buffer (pH 
7.4, containing 2 mM Na,VO,, 10 mM NaF, 10 mM pyrophosphate, 
1 mM EGTA, 1 mM PMSF, lo&ml leupeptin, 137 mM NaCI, 2.7 
mM KCl, 8.0 mM Na,HPO,, 1.5 mM KH,PO,) and vigorously stirred. 
Next, 50 ,uI of electrophoresis loading buffer (42 mM Tris, pH 6.8, 
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Fig. 3. Lineweaver-Burk plot of tyrosine kinase reaction with desmal. (A) A Lineweaver-Burk plot showing non-competitive inhibition by desmal 
against ATP. Inhibitor concentrations are 0 (o), 2.5 (A), and 5 (n),@ml, respectively. (B) A Lineweaver-Burk plot showing competitive inhibition 
by desmal against histone. Inhibitor concentrations were 0 (o), 1 .O (A), and 5 (0) &ml, respectively. 
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Fig. 4. Inhibition by desmal of intracellular tyrosine phosphorylation 
in ER12 cells. ER12 cells were incubated without (lane 1 and 2) or with 
desmal (lane 3, 50 &ml, lane 4,25 fig/ml) for 4 h and then incubated 
with EGF (100 @ml, lanes 2-4) for 5 min. Then, the cells were 
solubilized, electrophoresed, and reacted with anti-phosphotyrosine 
antibody as described in Section 2. 
containing 10% 2-mercaptoethanol, 10% glycerol, 8% SDS, and 
0.002% bromophenol blue) was added to the mixture, which was then 
boiled for 5 min and centrifuged at 12,000 rpm for 20 min. The 
supematant was electrophoresed on an SDS-polyacrylamide gel, after 
which the gel was reacted with anti-phosphotyrosine antibody (PY20, 
Seikagaku Kogyo Co., Ltd.). 
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2.8. Inositol phosphate formation 
ER12 cells (3 x 105) were plated in 24-well plates and cultured in 1 
ml of DMEM containing 5% calf serum for 48 h, during which period 
the cells became quiescent. They were then prelabeled with [‘H]inositol 
(1 @/ml) in inositol-free DMEM for 18 h, washed twice with 0.5 ml 
of DMEM, and given 0.5 ml of DMEM containing 30 mM LiCl and 
desmal (cl00 &ml). After incubation for 30 min, EGF (100 &ml) 
was added and the cells were further incubated for 5 min. The reaction 
was terminated by the addition of ice-cold 10% perchloric acid, and 
then the mixture was neutralized by 1.53 M KOH in 75 mM HEPES. 
The solution was kept on ice for 15 min, after which it was centrifuged 
at 15,000 x g for 10 min at 4°C. The supematant was applied onto an 
Amprep SAX column, which was then washed with water and eluted 
with 0.17 mM KHC03. The obtained eluate was counted with a liquid 
scintillation counter. 
2.9. Fluorescent staining offiamentous actin 
ER12 cells (1 x 10’) were plated in 12-well plates and cultured in 1 
ml of DMEM containing 1% calf serum for 16 h without or with 
desmal (50 pg/ml) and EGF (100 &ml). Then, the cells were fixed 
with 3.5% paraformaldehyde in CaZ’/Mg2’-free PBS for 20 min at 
room temperature. After a brief rinse in the Ca”/M$-free PBS, the 
fixed cells were exposed to acetone for 5 min at -20°C. The cells were 
washed again with Ca*‘/Mg2’-free PBS and incubated with rhodam- 
ine-conjugated phalloidin for 20 min at 37°C. They were washed with 
Ca*‘/Mg”-free PBS a final time and sealed in glycerin buffer. The cells 
were examined by fluorescence microscopy. 
3. RESULTS 
The chloroform extract of Desmos chinensis leaves 
showed potent inhibitory activity toward EGF recep- 
tor-associated tyrosine kinase activity. The active frac- 
tion was purified by chromatography and crystallized. 
The molecular formula of the active substance was de- 
termined to be C,7H,406 based on FDMS spectral data 
(FDMS m/z 314) and elemental analysis (Found: C, 
Fig. 5. Inhibition by desmal of EGF-induced cytoskeletal changes in ER12 cells. ER12 cells were incubated with no addition (A), 100 rig/ml of 
EGF (B), or EGF and 50 pg/ml of desmal (C) in DMEM containing 1% calf serum for 16 h at 37°C. Then, the cells were stained with 
rhodamine-phalloidin as described in Section 2. 
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Fig. 6. Inhibition by desmal of inositol phosphate production in ER12 
cells. After treatment of quiescent ER12 cells with various concentra- 
tions of desmal for 30 min at 37°C EGF (100 ng/ml) was added to 
the cells and incubation continued for 5 min at 37°C. Total inositol 
phosphates were measured as described in Section 2. The results are 
mean f SD. of triplicate determinations. 
65.29; H, 4.62%; Calculated: C, 64.96; H, 4.49%). The 
structure was postulated by proton and carbon- 13 spec- 
troscopy, and determined by X-ray crystallographic 
analysis to be 8-formyl-2,5,7-trihydroxy-6-methylflava- 
none, as shown in Fig. 2. As it had not been isolated 
previously, we named it desmal. 
Desmal inhibited EGF receptor-associated tyrosine 
kinase with an IC,, of 2.5 pg/ml. Lineweaver-Burk plot- 
ting with histone as a substrate showed that desmal 
competed with the protein but not with ATP, as shown 
in Fig. 3. 
Desmal inhibited intracellular tyrosine phosphoryla- 
tion in EGF receptor-overexpressing NIH3T3 (ER12) 
cells at 25-50 &ml, as shown in Fig. 4. EGF induces 
cytoskeletal changes in ER12 cells in 16 h [l 11, and 
desmal inhibited such changes at 50 &ml, as shown in 
Fig. 5. We found earlier that EGF induces inositol 
phosphate formation in ER12 cells as in A43 1 cells [ 121. 
The EGF-induced activation of inositol phosphate for- 
mation was inhibited by desmal at 25-100 ,&ml, as 
shown in Fig. 6. 
4. DISCUSSION 
The structure of desmal was predicted by NMR as 
one of the possible forms of a plant product from Unona 
lawii, 3-formyl-2,6-dihydroxy-4-methoxy-5-methyldi- 
benzoylmethane, in acetone-d, solvent [13], but it was 
never isolated. We isolated desmal from a different 
plant and determined its structure by X-ray crystallog- 
raphy. 
As a tyrosine kinase inhibitor desmal competed with 
the peptide substrate. It is rather unexpected since all 
isoflavonoids such as genistein and orobol inhibit tyro- 
sine kinase by competing with ATP. A substrate-com- 
petitive inhibitor would be advantageous for specific 
inhibition of tyrosine kinase. Desmal did not inhibit 
protein kinase C or phosphatidylinositol kinase at 100 
&ml. 
Desmal inhibited the growth of A431 cells, ER12 
cells, and temperature-sensitive Rous sarcoma virus- 
transformed NRK (RSV’“-NRK) cells at 33°C and 
39°C with IC,,s of 26,3 1, 14, and 13 &ml, respectively. 
In EGF-overexpressing fibroblasts desmal modified the 
EGF-induced phenotypic change. Therefore, it may be 
a tool to study the role of tyrosine kinase in various 
cellular events. 
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